Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Autoantibodies"" wg kryterium: Temat


Tytuł :
Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.
Autorzy :
Richter AG; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Shields AM; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Karim A; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Birch D; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Faustini SE; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Steadman L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Ward K; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Plant T; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Reynolds G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Veenith T; Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, Birmingham, UK.
Cunningham AF; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Drayson MT; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Wraith DC; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Pokaż więcej
Źródło :
Clinical and experimental immunology [Clin Exp Immunol] 2021 Aug; Vol. 205 (2), pp. 99-105. Date of Electronic Publication: 2021 Jun 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibody Specificity*
Autoantibodies*/blood
Autoantibodies*/immunology
COVID-19*/blood
COVID-19*/immunology
SARS-CoV-2*/immunology
SARS-CoV-2*/metabolism
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Organ Specificity ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Development of ACE2 autoantibodies after SARS-CoV-2 infection.
Autorzy :
Arthur JM; Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.; Central Arkansas Veterans Healthcare System, Little Rock, AR, United States of America.
Forrest JC; Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.; Center for Microbial Pathogenesis and Host Inflammatory Responses, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.
Boehme KW; Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.; Center for Microbial Pathogenesis and Host Inflammatory Responses, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.
Kennedy JL; Center for Microbial Pathogenesis and Host Inflammatory Responses, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.; Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.
Owens S; Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.
Herzog C; Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.
Liu J; Department of Pathology and Laboratory Services, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.
Harville TO; Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.; Department of Pathology and Laboratory Services, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Sep 03; Vol. 16 (9), pp. e0257016. Date of Electronic Publication: 2021 Sep 03 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Autoantibodies/*blood
COVID-19/*immunology
SARS-CoV-2/*isolation & purification
Spike Glycoprotein, Coronavirus/*blood
Angiotensin II/blood ; Angiotensin II/immunology ; Angiotensin-Converting Enzyme 2/genetics ; Autoantibodies/immunology ; Autoantibodies/isolation & purification ; COVID-19/blood ; COVID-19/virology ; Female ; Humans ; Male ; Peptidyl-Dipeptidase A/blood ; Receptor, Angiotensin, Type 1/blood ; Receptor, Angiotensin, Type 1/genetics ; Receptor, Angiotensin, Type 1/immunology ; Renin-Angiotensin System/genetics ; Renin-Angiotensin System/immunology ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; Spike Glycoprotein, Coronavirus/immunology ; Spike Glycoprotein, Coronavirus/isolation & purification
Czasopismo naukowe
Tytuł :
Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the PRe-clinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort.
Autorzy :
Costello RE; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Humphreys JH; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.; Kellgren Centre for Rheumatology, Manchester University NHS Foundation Trust, Manchester, UK.
Sergeant JC; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.; Centre for Biostatistics, School of Health Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Haris M; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Stirling F; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Raza K; NIHR Birmingham Biomedical Research Centre, Birmingham, UK.; Research into Inflammatory Arthritis Centre Versus Arthritis and MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, University of Birmingham, Birmingham, UK.; Sandwell and West Birmingham NHS Trust, Birmingham, UK.
van Schaardenburg D; Amsterdam Rheumatology and immunology Center, location Reade and Amsterdam University Medical Center, Amsterdam, the Netherlands.
Bruce IN; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. .; Kellgren Centre for Rheumatology, Manchester University NHS Foundation Trust, Manchester, UK. .; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. .; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK. .
Pokaż więcej
Źródło :
Arthritis research & therapy [Arthritis Res Ther] 2021 Aug 11; Vol. 23 (1), pp. 210. Date of Electronic Publication: 2021 Aug 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Arthritis, Rheumatoid*/diagnosis
Arthritis, Rheumatoid*/epidemiology
Autoantibodies*
Aged ; Cross-Sectional Studies ; Humans ; Peptides, Cyclic ; Rheumatoid Factor ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Multiple Sclerosis: Enzymatic Cross Site-Specific Hydrolysis of H1 Histone by IgGs against H1, H2A, H2B, H3, H4 Histones, and Myelin Basic Protein.
Autorzy :
Nevinsky GA; Siberian Division, Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Lavrentiev Ave. 8, 630090 Novosibirsk, Russia.
Baranova SV; Siberian Division, Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Lavrentiev Ave. 8, 630090 Novosibirsk, Russia.
Buneva VN; Siberian Division, Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Lavrentiev Ave. 8, 630090 Novosibirsk, Russia.
Dmitrenok PS; Far East Division, Pacific Institute of Bioorganic Chemistry, Russian Academy of Sciences, 690022 Vladivostok, Russia.
Pokaż więcej
Źródło :
Biomolecules [Biomolecules] 2021 Aug 02; Vol. 11 (8). Date of Electronic Publication: 2021 Aug 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Catalytic/*chemistry
Autoantibodies/*chemistry
Histones/*chemistry
Immunoglobulin G/*chemistry
Multiple Sclerosis/*blood
Myelin Basic Protein/*chemistry
Amino Acid Sequence ; Antibodies, Catalytic/blood ; Antibodies, Catalytic/isolation & purification ; Autoantibodies/blood ; Autoantibodies/isolation & purification ; Binding Sites ; Chromatography, Affinity ; Histones/blood ; Histones/immunology ; Humans ; Hydrolysis ; Immunoglobulin G/blood ; Immunoglobulin G/isolation & purification ; Multiple Sclerosis/immunology ; Multiple Sclerosis/pathology ; Myelin Basic Protein/blood ; Myelin Basic Protein/immunology ; Protein Binding ; Protein Isoforms/blood ; Protein Isoforms/chemistry ; Protein Isoforms/immunology ; Proteolysis ; Substrate Specificity
Czasopismo naukowe
Tytuł :
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
Autorzy :
Lingel H; Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Meltendorf S; Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Billing U; Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Thurm C; Institute of Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Vogel K; Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Majer C; Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Prätsch F; Department of Anesthesiology and Intensive Care Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Roggenbuck D; Faculty of Health Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Cottbus, Germany.
Heuft HG; Department of Transfusion Medicine and Immunohematology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Hachenberg T; Department of Anesthesiology and Intensive Care Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Feist E; Department of Rheumatology, Helios Specialist Hospital Vogelsang, Gommern, Germany.
Reinhold D; Institute of Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Brunner-Weinzierl MC; Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany. Electronic address: .
Pokaż więcej
Źródło :
Journal of autoimmunity [J Autoimmun] 2021 Aug; Vol. 122, pp. 102682. Date of Electronic Publication: 2021 Jun 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*blood
COVID-19/*immunology
Peptides, Cyclic/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Citrullinated Protein Antibodies/blood ; Anti-Citrullinated Protein Antibodies/immunology ; Arthritis, Rheumatoid/immunology ; Autoantibodies/immunology ; Autoantigens/immunology ; Celiac Disease/immunology ; Female ; Humans ; Male ; Middle Aged ; Prevalence ; Prospective Studies ; SARS-CoV-2 ; Transglutaminases/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
Autorzy :
Lopez J; Molecular biology core facility, Civils Hospices of Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
Mommert M; Joint Research Unit Civils Hospices of Lyon-bioMérieux, Civils Hospices of Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; Open Innovation & Partnerships, bioMérieux S.A., Marcy l'Etoile, France.
Mouton W; Joint Research Unit Civils Hospices of Lyon-bioMérieux, Civils Hospices of Lyon, Lyon Sud Hospital, Pierre-Bénite, France.; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.
Pizzorno A; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.
Brengel-Pesce K; Joint Research Unit Civils Hospices of Lyon-bioMérieux, Civils Hospices of Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
Mezidi M; Intensive Care Medicine, Croix-Rousse hospital, Claude Bernard Lyon 1 University, Lyon, France.
Villard M; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.
Lina B; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.; Virology laboratory, Institute of Infectious Agents, Laboratory associated with the National Reference Centre for Respiratory Viruses, Civils Hospices of Lyon, Lyon, France.
Richard JC; Intensive Care Medicine, Croix-Rousse hospital, Claude Bernard Lyon 1 University, Lyon, France.
Fassier JB; Occupational Health and Medicine Department, Hospices Civils de Lyon, Lyon, France.; Université Claude Bernard Lyon 1, Institut français des sciences et technologies des transports, de l'aménagement et des reseaux, Unité Mixte de Recherche Epidémiologique et de Surveillance Transport Travail Environnement, UMR T_9405, Lyon University, Lyon, France.
Cheynet V; Joint Research Unit Civils Hospices of Lyon-bioMérieux, Civils Hospices of Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
Padey B; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.; Signia Therapeutics SAS, Lyon, France.
Duliere V; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.; VirNext, Faculty of Medicine RTH Laennec, Claude Bernard Lyon 1 University, Lyon University, Lyon, France.
Julien T; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.; VirNext, Faculty of Medicine RTH Laennec, Claude Bernard Lyon 1 University, Lyon University, Lyon, France.
Paul S; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.
Bastard P; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
Belot A; Open Innovation & Partnerships, bioMérieux S.A., Marcy l'Etoile, France.; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.
Bal A; Intensive Care Medicine, Croix-Rousse hospital, Claude Bernard Lyon 1 University, Lyon, France.; Virology laboratory, Institute of Infectious Agents, Laboratory associated with the National Reference Centre for Respiratory Viruses, Civils Hospices of Lyon, Lyon, France.
Casanova JL; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.; Howard Hughes Medical Institute, New York, NY.
Rosa-Calatrava M; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.; VirNext, Faculty of Medicine RTH Laennec, Claude Bernard Lyon 1 University, Lyon University, Lyon, France.
Morfin F; Intensive Care Medicine, Croix-Rousse hospital, Claude Bernard Lyon 1 University, Lyon, France.; Virology laboratory, Institute of Infectious Agents, Laboratory associated with the National Reference Centre for Respiratory Viruses, Civils Hospices of Lyon, Lyon, France.
Walzer T; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.
Trouillet-Assant S; International Center of Research in Infectiology, Institut National de la Santé et de la Recherche Médicale U1111, Centre National de la Recherche Scientifique UMR5308, École normale supérieure Lyon, Claude Bernard Lyon 1 University, Lyon, Rhône, France.
Pokaż więcej
Źródło :
The Journal of experimental medicine [J Exp Med] 2021 Oct 04; Vol. 218 (10). Date of Electronic Publication: 2021 Aug 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*immunology
COVID-19/*immunology
Interferon Type I/*immunology
SARS-CoV-2/*immunology
Adult ; Aged ; Animals ; Antiviral Agents/immunology ; Antiviral Agents/pharmacology ; Autoantibodies/blood ; COVID-19/blood ; COVID-19/virology ; Chlorocebus aethiops ; Female ; Humans ; Interferon Type I/pharmacology ; Longitudinal Studies ; Male ; Middle Aged ; Nasal Cavity/immunology ; Nasal Cavity/virology ; Prospective Studies ; SARS-CoV-2/physiology ; Vero Cells ; Viral Load/drug effects ; Viral Load/immunology ; Virus Replication/drug effects ; Virus Replication/immunology
Czasopismo naukowe
Tytuł :
GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice.
Autorzy :
Scheggia D; Department of Pharmacological and Biomolecular Sciences (DiSFeB), University of Milan, 20133 Milan, Italy.
Stanic J; Department of Pharmacological and Biomolecular Sciences (DiSFeB), University of Milan, 20133 Milan, Italy.
Italia M; Department of Pharmacological and Biomolecular Sciences (DiSFeB), University of Milan, 20133 Milan, Italy.
La Greca F; Department of Pharmacological and Biomolecular Sciences (DiSFeB), University of Milan, 20133 Milan, Italy.
Zianni E; Department of Pharmacological and Biomolecular Sciences (DiSFeB), University of Milan, 20133 Milan, Italy.
Benussi A; Neurology Unit, Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, 25123, Brescia, Italy.
Borroni B; Neurology Unit, Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, 25123, Brescia, Italy.
Di Luca M; Department of Pharmacological and Biomolecular Sciences (DiSFeB), University of Milan, 20133 Milan, Italy.
Gardoni F; Department of Pharmacological and Biomolecular Sciences (DiSFeB), University of Milan, 20133 Milan, Italy. Electronic address: .
Pokaż więcej
Źródło :
Brain, behavior, and immunity [Brain Behav Immun] 2021 Oct; Vol. 97, pp. 89-101. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies*
Receptors, AMPA*/metabolism
Animals ; Dendritic Spines/metabolism ; Hippocampus/metabolism ; Humans ; Mice ; Synapses/metabolism
Czasopismo naukowe
Tytuł :
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19.
Autorzy :
van der Wijst MGP; Department of Genetics, University of Groningen, University Medical Center Groningen, 9713AV Groningen, Netherlands.; Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.; Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Vazquez SE; Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA 94143, USA.; Tetrad Graduate Program, University of California, San Francisco, San Francisco, CA 94143, USA.; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.
Hartoularos GC; Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.; Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Bastard P; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, 75015 Paris, France.; University of Paris, Imagine Institute, 75015 Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA.
Grant T; Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.; Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Bueno R; Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.; Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Lee DS; Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.; Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA 94143, USA.
Greenland JR; Department of Medicine, University of California, San Francisco, San Francisco Medical Service, San Francisco Veterans Affairs Health Care System, San Francisco, CA 94121, USA.
Sun Y; Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.; Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA 94143, USA.
Perez R; Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.; School of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Ogorodnikov A; Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.; Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Ward A; Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.; Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Mann SA; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Lynch KL; Zuckerberg San Francisco General, San Francisco, CA 94110, USA.; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Yun C; Zuckerberg San Francisco General, San Francisco, CA 94110, USA.; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Havlir DV; Division of HIV, Infectious Disease and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Chamie G; Division of HIV, Infectious Disease and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Marquez C; Division of HIV, Infectious Disease and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Greenhouse B; Division of HIV, Infectious Disease and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Lionakis MS; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20814, USA.
Norris PJ; Zuckerberg San Francisco General, San Francisco, CA 94110, USA.; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.; Vitalant Research Institute, San Francisco, CA 94118, USA.
Dumont LJ; Vitalant Research Institute, Denver, CO 80230, USA.; University of Colorado School of Medicine, Aurora, CO 80045, USA.; Geisel School of Medicine at Dartmouth, Lebanon, NH 03755, USA.
Kelly K; Vitalant Research Institute, Denver, CO 80230, USA.
Zhang P; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA.
Zhang Q; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA.
Gervais A; University of Paris, Imagine Institute, 75015 Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA.
Le Voyer T; University of Paris, Imagine Institute, 75015 Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA.
Whatley A; Department of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley, CA 94720, USA.
Si Y; Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA.
Byrne A; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Combes AJ; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA 94143, USA.; Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA.; UCSF CoLabs, University of California, San Francisco, San Francisco, CA 94143, USA.
Rao AA; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA 94143, USA.; Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA.; UCSF CoLabs, University of California, San Francisco, San Francisco, CA 94143, USA.
Song YS; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.; Department of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley, CA 94720, USA.; Department of Statistics, University of California, Berkeley, Berkeley, CA 94720, USA.
Fragiadakis GK; Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA 94143, USA.; UCSF CoLabs, University of California, San Francisco, San Francisco, CA 94143, USA.
Kangelaris K; Division of Hospital Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Calfee CS; Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine and the Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA.
Erle DJ; Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA 94143, USA.; Zuckerberg San Francisco General, San Francisco, CA 94110, USA.
Hendrickson C; Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine and the Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA.
Krummel MF; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA 94143, USA.; Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA.
Woodruff PG; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA 94143, USA.; Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine and the Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA.
Langelier CR; Division of Infectious Disease, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Casanova JL; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, 75015 Paris, France.; University of Paris, Imagine Institute, 75015 Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA.; Howard Hughes Medical Institute, New York, NY 10065, USA.
Derisi JL; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Anderson MS; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Ye CJ; Institute of Human Genetics, University of California, San Francisco, San Francisco, CA 94143, USA.; Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA 94143, USA.; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.; Departments of Epidemiology and Biostatistics and Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA 94143, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA.
Pokaż więcej
Corporate Authors :
UCSF COMET consortium
Źródło :
Science translational medicine [Sci Transl Med] 2021 Sep 22; Vol. 13 (612), pp. eabh2624. Date of Electronic Publication: 2021 Aug 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Autoantibodies*/immunology
COVID-19*/immunology
Interferon Type I*/immunology
Humans
Czasopismo naukowe
Tytuł :
New-onset IgG autoantibodies in hospitalized patients with COVID-19.
Autorzy :
Chang SE; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Feng A; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Meng W; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Apostolidis SA; Department of Medicine, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Mack E; Department of Hematology, Oncology, Immunology, Philipps University Marburg, Marburg, Germany.
Artandi M; Department of Medicine, Division of Primary Care and Population Health, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Stanford CROWN Clinic, Stanford University School of Medicine, Stanford, CA, USA.
Barman L; Department of Medicine, Division of Primary Care and Population Health, Stanford University School of Medicine, Stanford, CA, USA.
Bennett K; Molecular Pathology and Imaging Core, Department of Medicine, Gastroenterology Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Chakraborty S; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Chang I; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA, USA.
Cheung P; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Chinthrajah S; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA, USA.
Dhingra S; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Do E; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA, USA.
Finck A; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Gaano A; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Geßner R; Institute of Laboratory Medicine, Philipps University Marburg, Marburg, Germany.
Giannini HM; Department of Microbiology, Immunology and Biochemistry, The University of Tennessee Health Science Center, Memphis, TN, USA.
Gonzalez J; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Greib S; Institute of Laboratory Medicine, Philipps University Marburg, Marburg, Germany.
Gündisch M; Institute of Laboratory Medicine, Philipps University Marburg, Marburg, Germany.
Hsu AR; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Kuo A; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Manohar M; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Mao R; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Neeli I; Department of Microbiology, Immunology and Biochemistry, The University of Tennessee Health Science Center, Memphis, TN, USA.
Neubauer A; Department of Hematology, Oncology, Immunology, Philipps University Marburg, Marburg, Germany.
Oniyide O; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Powell AE; Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA.; ChEM-H, Stanford University, Stanford, USA.
Puri R; Department of Medicine, Division of Primary Care and Population Health, Stanford University School of Medicine, Stanford, CA, USA.
Renz H; Institute of Laboratory Medicine, Philipps University Marburg, Marburg, Germany.; Member of the Universities of Giessen and Marburg Lung Center (UGMLC), and the German Center for Lung Research (DZL), Giessen, Germany.
Schapiro J; TPMG Regional Reference Laboratory, Kaiser Permanente Northern California, Berkeley, CA, USA.
Weidenbacher PA; Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA.; ChEM-H, Stanford University, Stanford, USA.
Wittman R; Department of Medicine, Division of Primary Care and Population Health, Stanford University School of Medicine, Stanford, CA, USA.
Ahuja N; Department of Medicine, Division of Hospital Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Chung HR; Institute for Medical Bioinformatics and Biostatistics, Philipps University Marburg, Marburg, Germany.
Jagannathan P; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
James JA; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Kim PS; Department of Microbiology, Immunology and Biochemistry, The University of Tennessee Health Science Center, Memphis, TN, USA.; Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA.
Meyer NJ; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Nadeau KC; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA, USA.
Radic M; Department of Microbiology, Immunology and Biochemistry, The University of Tennessee Health Science Center, Memphis, TN, USA.
Robinson WH; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.; VA Palo Alto Health Care System, Palo Alto, CA, USA.
Singh U; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
Wang TT; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA.
Wherry EJ; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Skevaki C; Institute of Laboratory Medicine, Philipps University Marburg, Marburg, Germany. .; Member of the Universities of Giessen and Marburg Lung Center (UGMLC), and the German Center for Lung Research (DZL), Giessen, Germany. .
Luning Prak ET; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. .; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. .
Utz PJ; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA. .; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Sep 14; Vol. 12 (1), pp. 5417. Date of Electronic Publication: 2021 Sep 14.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*immunology
COVID-19/*immunology
Immunoglobulin G/*immunology
SARS-CoV-2/*immunology
Aged ; Antibodies, Antinuclear/blood ; Antibodies, Antinuclear/immunology ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Autoantibodies/blood ; Autoantigens/immunology ; Connective Tissue Diseases/immunology ; Cytokines/immunology ; Female ; Hospitalization ; Humans ; Immunoglobulin G/blood ; Male ; Middle Aged ; SARS-CoV-2/pathogenicity ; Viral Proteins/immunology
Czasopismo naukowe
Tytuł :
Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19.
Autorzy :
Gomes C; Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Zuniga M; Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Crotty KA; Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.
Qian K; Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Tovar NC; Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA.; Universidad de Córdoba, Montería, Córdoba, Colombia.; Universidad Del Sinú, Montería, Córdoba, Colombia.
Lin LH; Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA.
Argyropoulos KV; Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA.
Clancy R; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Izmirly P; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Buyon J; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Lee DC; Department of Emergency Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Yasnot-Acosta MF; Universidad de Córdoba, Montería, Córdoba, Colombia.
Li H; Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Cotzia P; Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA.
Rodriguez A; Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA .
Pokaż więcej
Źródło :
Life science alliance [Life Sci Alliance] 2021 Sep 09; Vol. 4 (11). Date of Electronic Publication: 2021 Sep 09 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Antinuclear/*immunology
Autoantibodies/*immunology
COVID-19/*immunology
COVID-19/*metabolism
Adult ; Aged ; Aged, 80 and over ; Antibodies, Antinuclear/blood ; Autoantibodies/blood ; Biomarkers ; DNA/chemistry ; DNA/immunology ; Erythrocytes/immunology ; Female ; Humans ; Male ; Middle Aged ; Phosphatidylserines/immunology ; Prognosis ; Retrospective Studies ; SARS-CoV-2/isolation & purification ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Anti-MDA-5-positive dermatomyositis associated rapidly progressive interstitial lung disease, a virus-triggered autoimmune-like symptom?
Autorzy :
Xu L; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, China, Nanjing, Jiangsu, China.
Wang L; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, China, Nanjing, Jiangsu, China.
Lv C; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, China, Nanjing, Jiangsu, China.
Tan W; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, China, Nanjing, Jiangsu, China.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2021 Sep 01; Vol. 60 (9), pp. 4428-4429.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies*
Dermatomyositis/*immunology
Interferon-Induced Helicase, IFIH1/*immunology
Lung Diseases, Interstitial/*immunology
Dermatomyositis/complications ; Disease Progression ; Humans ; Lung Diseases, Interstitial/etiology
Raport
Tytuł :
Modified recombinant human IgG1-Fc is superior to natural intravenous immunoglobulin at inhibiting immune-mediated demyelination.
Autorzy :
Baksmeier C; Department of Neurology, Medical Faculty, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
Blundell P; Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Steckel J; Department of Neurology, Medical Faculty, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
Schultz V; Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Gu Q; Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Da Silva Filipe A; Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Kohl A; Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Linnington C; Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Lu D; Department of Life Sciences, Imperial College London, London, UK.
Dell A; Department of Life Sciences, Imperial College London, London, UK.
Haslam S; Department of Life Sciences, Imperial College London, London, UK.
Wang J; Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Czajkowsky D; State Key Laboratory for Oncogenes and Related Genes and Bio-ID Center, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Goebels N; Department of Neurology, Medical Faculty, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
Pleass RJ; Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Pokaż więcej
Źródło :
Immunology [Immunology] 2021 Sep; Vol. 164 (1), pp. 90-105. Date of Electronic Publication: 2021 May 09.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*therapeutic use
Cerebellum/*pathology
Demyelinating Diseases/*therapy
Immunoglobulin Fc Fragments/*therapeutic use
Immunoglobulin G/*therapeutic use
Oligodendroglia/*pathology
Recombinant Fusion Proteins/*therapeutic use
Animals ; Autoantibodies/genetics ; Cerebellum/drug effects ; Demyelinating Diseases/immunology ; HEK293 Cells ; Humans ; Immunoglobulin Fc Fragments/genetics ; Immunoglobulin G/genetics ; Immunoglobulins, Intravenous/therapeutic use ; Mice ; Mice, Inbred C57BL ; Myelin-Oligodendrocyte Glycoprotein/immunology ; Oligodendroglia/drug effects ; Organ Culture Techniques ; Recombinant Fusion Proteins/genetics
Czasopismo naukowe
Tytuł :
Autoantibodies in moderate and critical cases of COVID-19.
Autorzy :
Chang SH; Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, Korea.
Minn D; Department of Diagnostic Immunology, Seegene Medical Foundation, Seoul, Korea.
Kim YK; Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, Korea.
Pokaż więcej
Źródło :
Clinical and translational science [Clin Transl Sci] 2021 Sep; Vol. 14 (5), pp. 1625-1626. Date of Electronic Publication: 2021 May 02.
Typ publikacji :
Letter; Observational Study
MeSH Terms :
Autoantibodies/*blood
COVID-19/*diagnosis
COVID-19 Serological Testing/*methods
SARS-CoV-2/*immunology
Adult ; Aged ; Aged, 80 and over ; Autoantibodies/immunology ; COVID-19/blood ; COVID-19/immunology ; COVID-19/virology ; COVID-19 Nucleic Acid Testing ; Female ; Humans ; Male ; Middle Aged ; RNA, Viral/isolation & purification ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; Severity of Illness Index
Raport
Tytuł :
Case of pemphigoid with antibodies to BP180 C-terminal domain and α3 subunit of laminin-332 associated with chronic graft-versus-host disease.
Autorzy :
Kawashima H; Department of Dermatology, Tokushima University School of Medicine, Tokushima, Japan.
Kageji R; Department of Dermatology, Tokushima Red Cross Hospital, Tokushima, Japan.
Hida Y; Department of Dermatology, Tokushima Red Cross Hospital, Tokushima, Japan.
Goto T; Department of Hematology, Tokushima Red Cross Hospital, Tokushima, Japan.
Ishii N; Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan.
Hashimoto T; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Pokaż więcej
Źródło :
The Journal of dermatology [J Dermatol] 2021 Sep; Vol. 48 (9), pp. e447-e448. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Autoantibodies*
Graft vs Host Disease*/diagnosis
Pemphigoid, Benign Mucous Membrane*
Pemphigoid, Bullous*/diagnosis
Aged ; Autoantigens/immunology ; Humans ; Laminin/immunology ; Male ; Non-Fibrillar Collagens/immunology
Raport
Tytuł :
Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.
Autorzy :
Bastard P; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France. .; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Gervais A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Le Voyer T; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Rosain J; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Philippot Q; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Manry J; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Michailidis E; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Hoffmann HH; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Eto S; Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Garcia-Prat M; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Catalonia, Spain.
Bizien L; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Parra-Martínez A; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Catalonia, Spain.
Yang R; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Haljasmägi L; Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Migaud M; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Särekannu K; Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Maslovskaja J; Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
de Prost N; Service de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor, Assistance Publique - Hôpitaux de Paris (AP-HP).; Groupe de Recherche Clinique CARMAS, Faculté de Santé de Créteil, Université Paris Est Créteil, 51, Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil Cedex, France.
Tandjaoui-Lambiotte Y; Avicenne Hospital, Assistance Publique Hôpitaux de Paris, Bobigny, INSERM U1272 Hypoxia & Lung, Bobigny, France.
Luyt CE; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Médecine Intensive Réanimation, AP-HP, Paris, France.; INSERM UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Paris, France.
Amador-Borrero B; Internal Medicine Department, Lariboisière Hospital, AP-HP, Paris University, Paris, France.
Gaudet A; University of Lille, U1019-UMR9017-Center for Infection and Immunity of Lille, Lille, France.; CNRS, UMR9017, Lille, France.; INSERM, U1019, Lille, France.; Institut Pasteur de Lille, Lille, France.; CHU Lille, Pôle de Réanimation, Hôpital Roger Salengro, Lille, France.
Poissy J; University of Lille, U1019-UMR9017-Center for Infection and Immunity of Lille, Lille, France.; CNRS, UMR9017, Lille, France.; INSERM, U1019, Lille, France.; Institut Pasteur de Lille, Lille, France.; CHU Lille, Pôle de Réanimation, Hôpital Roger Salengro, Lille, France.
Morel P; Etablissement Français du Sang, La Plaine-St Denis, France.; UMR 1098 RIGHT, Inserm, EFS, Université de Franche-Comté, Besançon, France.
Richard P; Etablissement Français du Sang, La Plaine-St Denis, France.
Cognasse F; SAINBIOSE, INSERM U1059, University of Lyon, Université Jean-Monnet-Saint-Etienne.; Etablissement Français du Sang, Auvergne Rhône-Alpes, St-Etienne, St-Etienne, France.
Troya J; Department of Internal Medicine, Infanta Leonor University Hospital, Madrid, Spain.
Trouillet-Assant S; Hospices Civils de Lyon, Lyon, France; International Center of Research in Infectiology, Lyon University, INSERM U1111, CNRS UMR 5308, ENS, UCBL, Lyon, France.
Belot A; Joint Research Unit, Hospices Civils de Lyon-bio Mérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France; International Center of Research in Infectiology, Lyon University, INSERM U1111, CNRS UMR 5308, ENS, UCBL, Lyon, France.; CNRS UMR 5308, ENS, UCBL, Lyon, France; National Referee Centre for Rheumatic, and Autoimmune and Systemic Diseases in Children (RAISE), Lyon, France; Lyon; Immunopathology Federation LIFE, Hospices Civils de Lyon, Lyon, France.
Saker K; Joint Research Unit, Hospices Civils de Lyon-bio Mérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France; International Center of Research in Infectiology, Lyon University, INSERM U1111, CNRS UMR 5308, ENS, UCBL, Lyon, France.
Garçon P; Intensive Care Unit, Grand Hôpital de l'Est Francilien Site de Marne-la-Vallée, Jossigny, France.
Rivière JG; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Catalonia, Spain.
Lagier JC; Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France.; Aix Marseille Université, IRD, APHM, MEPHI, Marseille, France.
Gentile S; Service d'Evaluation Médicale, Hôpitaux Universitaires de Marseille Assistance Publique Hôpitaux de Marseille (APHM), Marseille, France.; Aix Marseille University, School of Medicine - La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of Life Center, Marseille, France.
Rosen LB; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA.
Shaw E; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA.
Morio T; Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Tanaka J; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Dalmau D; Hospital Universitari Mutua Tarrassa, Tarrasa, Spain.
Tharaux PL; Paris Cardiovascular Center, PARCC, Inserm, Université de Paris, Paris, France.
Sene D; Internal Medicine Department, Lariboisière Hospital, AP-HP, Paris University, Paris, France.
Stepanian A; Service d'Hématologie Biologique, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris and EA3518, Institut Universitaire d'Hématologie-Hôpital Saint Louis, Université Paris Diderot, Paris, France.
Megarbane B; Réanimation Médicale et Toxicologique, Hôpital Lariboisière (AP-HP), Université Paris-Diderot, INSERM Unité Mixte de Recherche Scientifique (UMRS) 1144.
Triantafyllia V; Laboratory of Immunobiology, Center for Clinical, Experimental Surgery, and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
Fekkar A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; Service de Parasitologie-Mycologie, Groupe Hospitalier Pitié Salpêtrière, AP-HP, Paris, France.
Heath JR; Institute for Systems Biology, Seattle, WA 98109, USA.
Franco JL; Primary Immunodeficiencies Group, Department of Microbiology and Parasitology, School of Medicine, University of Antioquia UDEA, Medellín, Colombia.
Anaya JM; Center for Autoimmune Disease Research, School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia.
Solé-Violán J; Critical Care Unit, University Hospital of Gran Canaria Dr. Negrín, Canarian Health System, Las Palmas de Gran Canaria, Canary Islands, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Imberti L; CREA Laboratory, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy.
Biondi A; Pediatric Department and Centro Tettamanti-European Reference Network PaedCan, EuroBloodNet, MetabERN-University of Milano-Bicocca-Fondazione MBBM-Ospedale, San Gerardo, Monza, Italy.
Bonfanti P; Department of Infectious Diseases, San Gerardo Hospital-University of Milano-Bicocca, Monza, Italy.
Castagnoli R; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA.; Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Delmonte OM; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA.
Zhang Y; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA.; NIAID Clinical Genomics Program, National Institutes of Health, Bethesda, USA.
Snow AL; Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Holland SM; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA.
Biggs C; Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
Moncada-Vélez M; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Arias AA; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.; Primary Immunodeficiencies Group, University of Antioquia UdeA, Medellin, Colombia.; School of Microbiology, University of Antioquia UdeA, Medellin, Colombia.
Lorenzo L; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Boucherit S; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Coulibaly B; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Anglicheau D; Department of Nephrology and Transplantation, Necker University Hospital - APHP, Paris, France; INEM INSERM U 1151- CNRS UMR 8253, Paris University, Paris, France.
Planas AM; Institute for Biomedical Research, Spanish Research Council, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Haerynck F; Department of Paediatric Immunology and Pulmonology, Center for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Center, Ghent University Hospital, Ghent, Belgium.
Duvlis S; Faculty of Medical Sciences, University 'Goce Delchev', Stip, Republic of Northern Macedonia.; Institute of public health of Republic of North Macedonia.
Nussbaum RL; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, USA.
Ozcelik T; Department of Molecular Biology and Genetics, Bilkent University, Bilkent - Ankara, Turkey.
Keles S; Meram Medical Faculty, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey.
Bousfiha AA; Clinical Immunology Unit, Department of Pediatric Infectious Disease, CHU Ibn Rushd and LICIA, Laboratoire d'Immunologie Clinique, Inflammation et Allergie, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
El Bakkouri J; Clinical Immunology Unit, Department of Pediatric Infectious Disease, CHU Ibn Rushd and LICIA, Laboratoire d'Immunologie Clinique, Inflammation et Allergie, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
Ramirez-Santana C; Primary Immunodeficiencies Group, Department of Microbiology and Parasitology, School of Medicine, University of Antioquia UDEA, Medellín, Colombia.; Center for Autoimmune Disease Research, School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia.
Paul S; Department of Immunology, CIC1408, GIMAP CIRI INSERM U1111, University Hospital of Saint-Etienne, Saint-Etienne, France.
Pan-Hammarström Q; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Hammarström L; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Dupont A; Université de Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.
Kurolap A; The Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.
Metz CN; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Aiuti A; Pathogenesis and Therapy of Primary Immunodeficiencies Unit, San Raffaele, Milano, Italy.
Casari G; Pathogenesis and Therapy of Primary Immunodeficiencies Unit, San Raffaele, Milano, Italy.
Lampasona V; Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Ciceri F; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Barreiros LA; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Dominguez-Garrido E; Fundación Rioja Salud - Centro de Investigación Biomédica de La Rioja, Logrono, Spain.
Vidigal M; University of Sao Paulo, Sao Paulo, Brazil.
Zatz M; University of Sao Paulo, Sao Paulo, Brazil.
van de Beek D; Department of Neurology, Amsterdam Neuroscience, Amsterdam, Netherlands.
Sahanic S; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
Tancevski I; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
Stepanovskyy Y; Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
Boyarchuk O; Department of Children's Diseases and Pediatric Surgery, I.Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
Nukui Y; Department of Infection Control and Prevention, Medical Hospital, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Tsumura M; Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Vidaur L; Intensive Care Department, Donostia University Hospital, San Sebastian, Spain.; Centro de Investigación en Red de Enfermedades Respiratorias-CIBERES - Instituto de Salud Carlos III, Madrid, España.
Tangye SG; Garvan Institute of Medical Research, Sydney, Australia.
Burrel S; Sorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié Salpêtrière, Service de Virologie, Paris, France.
Duffy D; Translational Immunology Lab, Institut Pasteur.
Quintana-Murci L; Human Evolutionary Genetics Unit, Institut Pasteur, CNRS UMR 2000, Paris, France.; Chair of Human Genomics and Evolution, Collège de France, Paris, France.
Klocperk A; Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czech Republic.
Kann NY; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Shcherbina A; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Lau YL; Department of Paediatrics & Adolescent Medicine, The University of Hong Kong, Hong Kong, China.
Leung D; Department of Paediatrics & Adolescent Medicine, The University of Hong Kong, Hong Kong, China.
Coulongeat M; Division of Geriatric Medicine, Tours University Medical Center, Tours, France.
Marlet J; INSERM U1259, MAVIVH, Université de Tours, Tours, France.; Service de Bactériologie-Virologie-Hygiène, CHU de Tours, Tours, France.
Koning R; Department of Neurology, Amsterdam Neuroscience, Amsterdam, Netherlands.
Reyes LF; Department of Microbiology, Universidad de La Sabana, Chia, Colombia.; Department of Critical Care Medicine, Clinica Universidad de La Sabana, Chia, Colombia.
Chauvineau-Grenier A; Service de Biologie Médicale, CHI Robert Ballanger, Aulnay sous Bois, France.
Venet F; Laboratoire d'Immunologie, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France.; EA 7426 « Pathophysiology of Injury-Induced Immunosuppression », Université Claude Bernard Lyon 1 - Hospices Civils de Lyon, Hôpital Edouard Herriot - BioMérieux, Lyon, France.
Monneret G; Laboratoire d'Immunologie, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France.; EA 7426 « Pathophysiology of Injury-Induced Immunosuppression », Université Claude Bernard Lyon 1 - Hospices Civils de Lyon, Hôpital Edouard Herriot - BioMérieux, Lyon, France.
Nussenzweig MC; Laboratory of Molecular Immunology, Rockefeller University, New York, NY, USA.; Howard Hughes Medical Institute, New York, NY, USA.
Arrestier R; Service de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor, Assistance Publique - Hôpitaux de Paris (AP-HP).; Groupe de Recherche Clinique CARMAS, Faculté de Santé de Créteil, Université Paris Est Créteil, 51, Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil Cedex, France.
Boudhabhay I; Department of Nephrology and Transplantation, Necker University Hospital - APHP, Paris, France; INEM INSERM U 1151- CNRS UMR 8253, Paris University, Paris, France.
Baris-Feldman H; The Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Hagin D; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Wauters J; Medical Intensive care Unit, University Hospitals Leuven, Leuven, Belgium.
Meyts I; Laboratory of Inborn Errors of Immunity, Department of Immunology, Microbiology and Transplantation, KU Leuven, Leuven, Belgium.; Department of Pediatrics, Jeffrey Modell Diagnostic and Research Network Center, University Hospitals Leuven, Leuven, Belgium.
Dyer AH; Department of Age-Related Healthcare, Tallaght University Hospital & Department of Medical Gerontology, School of Medicine, Trinity College Dublin.
Kennelly SP; Department of Age-Related Healthcare, Tallaght University Hospital & Department of Medical Gerontology, School of Medicine, Trinity College Dublin.
Bourke NM; Department of Medical Gerontology, School of Medicine, Trinity College Dublin.
Halwani R; Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Sharif-Askari NS; Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Dorgham K; Sorbonne Université, Inserm, Centre d'Immunologie et des Maladies Infectieuses, (CIMI- Paris), Paris, France.
Sallette J; Cerba Health Care, Issy-les-Moulineaux, France.
Sedkaoui SM; Cerba Health Care, Issy-les-Moulineaux, France.
AlKhater S; Department of Pediatrics, King Fahad Hospital of the University, Al-Khobar, Saudi Arabia.; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Rigo-Bonnin R; Department of Clinical Laboratory, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.
Morandeira F; Department of Immunology, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.
Roussel L; Department of Medicine, Division of Infectious Diseases, McGill University Health Centre, Montréal, Québec, Canada.; Infectious Disease Susceptibility Program, Research Institute-McGill University Health Centre, Montréal, Québec, Canada.
Vinh DC; Department of Medicine, Division of Infectious Diseases, McGill University Health Centre, Montréal, Québec, Canada.; Infectious Disease Susceptibility Program, Research Institute-McGill University Health Centre, Montréal, Québec, Canada.
Ostrowski SR; Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Condino-Neto A; Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Prando C; Faculdades Pequeno Príncipe, Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Brazil.
Bonradenko A; Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
Spaan AN; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands.
Gilardin L; Service de Médecine Interne, Hôpital universitaire Jean-Verdier, AP-HP, Bondy, France.; INSERM U1138, Centre de Recherche des Cordeliers, Paris, France.
Fellay J; School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Swiss Institue of Bioinformatics, Lausanne, Switzerland.
Lyonnet S; Imagine Institute, Université de Paris, INSERM UMR 1163, Paris, France.
Bilguvar K; Yale Center for Genome Analysis, Yale School of Medicine, New Haven, CT, USA.; Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA.; Department of Medical Genetics, Acibadem University School of Medicine, Istanbul, Turkey.
Lifton RP; Yale Center for Genome Analysis, Yale School of Medicine, New Haven, CT, USA.; Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.; Laboratory of Human Genetics and Genomics, The Rockefeller University, New York, NY.
Mane S; Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Anderson MS; Diabetes Center, University of California, San Francisco, CA, USA.
Boisson B; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Béziat V; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Zhang SY; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Vandreakos E; Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Hermine O; University of Paris, Imagine Institute, Paris, France.; Department of Hematology, Necker Hospital, AP-HP, Paris, France.
Pujol A; Neurometabolic Diseases Laboratory, IDIBELL-Hospital Duran i Reynals, CIBERER U759, and Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Spain.
Peterson P; Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Mogensen TH; Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Rowen L; Institute for Systems Biology, Seattle, WA 98109, USA.
Mond J; ADMA Biologics Inc., Ramsey NJ.
Debette S; University of Bordeaux, INSERM, Bordeaux Population Health Center, UMR1219, F-33000 Bordeaux, France.; Bordeaux University Hospital, Department of Neurology, Institute of Neurodegenerative Diseases, F-33000 Bordeaux, France.
de Lamballerie X; IHU Méditerranée Infection, Unité des Virus Émergents, UVE: Aix Marseille University, IRD 190, INSERM 1207, Marseille, France.
Duval X; Inserm CIC 1425, Paris, France.; Université de Paris, IAME UMR-S 1137, INSERM, Paris, France.; AP-HP, Département Epidémiologie Biostatistiques et Recherche Clinique, Hôpital Bichat, Paris, France.; AP-HP, Bichat Claude Bernard Hospital, Infectious and Tropical Diseases Department, Paris, France.
Mentré F; Inserm CIC 1425, Paris, France.; Université de Paris, IAME UMR-S 1137, INSERM, Paris, France.; AP-HP, Département Epidémiologie Biostatistiques et Recherche Clinique, Hôpital Bichat, Paris, France.
Zins M; Université de Paris, Université Paris-Saclay, UVSQ, Inserm UMS11, Villejuif, France.
Soler-Palacin P; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Catalonia, Spain.
Colobran R; Immunology Division, Genetics Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, UAB, Barcelona, Catalonia, Spain.
Gorochov G; Sorbonne Université, Inserm, Centre d'Immunologie et des Maladies Infectieuses, (CIMI- Paris), Paris, France.; Département d'Immunologie, Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpétrière, Paris, France.
Solanich X; Department of Internal Medicine, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.
Susen S; Université de Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.
Martinez-Picado J; IrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.; Infectious Diseases and Immunity, Center for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
Raoult D; Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France.; Aix Marseille Université, IRD, APHM, MEPHI, Marseille, France.
Vasse M; Service de Biologie Clinique & UMR-S 1176, Hopital Foch, Suresnes, France.
Gregersen PK; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Piemonti L; Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Rodríguez-Gallego C; Hospital Universitario de Gran Canaria Dr Negrín, Canarian Health System, Canary Islands, Spain.; Department of Clinical Sciences, University Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Canary Islands, Spain.
Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA.
Su HC; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Kisand K; Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Okada S; Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Puel A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Jouanguy E; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Rice CM; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
Tiberghien P; Etablissement Français du Sang, La Plaine-St Denis, France.; UMR 1098 RIGHT, Inserm, EFS, Université de Franche-Comté, Besançon, France.
Zhang Q; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Cobat A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Abel L; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Casanova JL; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France. .; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.; Howard Hughes Medical Institute, New York, NY, USA.
Pokaż więcej
Corporate Authors :
HGID Lab
COVID Clinicians
COVID-STORM Clinicians
NIAID Immune Response to COVID Group
NH-COVAIR Study Group
Danish CHGE
Danish Blood Donor Study
St. James's Hospital
SARS CoV2 Interest group
French COVID Cohort Study Group
Imagine COVID-Group
Milieu Intérieur Consortium
CoV-Contact Cohort
Amsterdam UMC Covid-19
Biobank Investigators
COVID Human Genetic Effort
CONSTANCES cohort
3C-Dijon Study
Cerba Health-Care
Etablissement du Sang study group
Źródło :
Science immunology [Sci Immunol] 2021 Aug 19; Vol. 6 (62).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*immunology
COVID-19/*immunology
Interferon Type I/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/immunology ; Autoantibodies/blood ; COVID-19/mortality ; Case-Control Studies ; Child ; Child, Preschool ; Critical Illness ; Humans ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Infant ; Infant, Newborn ; Interferon-alpha/immunology ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
[Correlation between clinical manifestation, prognosis and antibody in anti-muscle-specific tyrosine kinase antibody positive myasthenia gravis].
Autorzy :
Tan Y; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.
Zhu L; Department of Nuclear Medicine, Peking Union Medical College (PUMC)Hospital, Chinese Academy of Medical Science,Beijing 100730,China.
Huang YY; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.
Shi JY; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.
Li J; Department of Neurology, the First Hospital of Tsinghua University, Beijing 100016, China.
Li K; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.
Guan YZ; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.
Cui LY; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.
Pokaż więcej
Źródło :
Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2021 Aug 17; Vol. 101 (31), pp. 2433-2437.
Typ publikacji :
Journal Article
MeSH Terms :
Autoantibodies*
Myasthenia Gravis*
Age of Onset ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Male ; Middle Aged ; Prognosis
Czasopismo naukowe
Tytuł :
Autoantibodies stabilize neutrophil extracellular traps in COVID-19.
Autorzy :
Zuo Y; Division of Rheumatology, Department of Internal Medicine.
Yalavarthi S; Division of Rheumatology, Department of Internal Medicine.
Navaz SA; Division of Rheumatology, Department of Internal Medicine.
Hoy CK; Division of Rheumatology, Department of Internal Medicine.
Harbaugh A; Division of Rheumatology, Department of Internal Medicine.
Gockman K; Division of Rheumatology, Department of Internal Medicine.
Zuo M; Division of Geriatric and Palliative Medicine, Department of Internal Medicine, and.
Madison JA; Division of Rheumatology, Department of Internal Medicine.; Division of Pediatric Rheumatology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
Shi H; Division of Rheumatology, Department of Internal Medicine.; Division of Rheumatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Kanthi Y; Division of Intramural Research National Heart, Lung and Blood Institute Bethesda, Maryland, USA.; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Knight JS; Division of Rheumatology, Department of Internal Medicine.
Pokaż więcej
Źródło :
JCI insight [JCI Insight] 2021 Aug 09; Vol. 6 (15). Date of Electronic Publication: 2021 Aug 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Autoantibodies/*immunology
COVID-19/*immunology
Extracellular Traps/*immunology
SARS-CoV-2/*immunology
Adolescent ; Adult ; Autoantibodies/blood ; COVID-19/blood ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Immunoglobulin M/blood ; Immunoglobulin M/immunology ; Male ; Middle Aged ; Neutrophils/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases.
Autorzy :
Simon Q; Université de Brest, INSERM, UMR1227, Centre Hospitalier Universitaire de Brest, Brest, France.
Grasseau A; Université de Brest, INSERM, UMR1227, Centre Hospitalier Universitaire de Brest, Brest, France.
Boudigou M; Université de Brest, INSERM, UMR1227, Centre Hospitalier Universitaire de Brest, Brest, France.
Le Pottier L; Université de Brest, INSERM, UMR1227, Centre Hospitalier Universitaire de Brest, Brest, France.
Bettachioli E; Centre Hospitalier Universitaire Morvan de Brest, Brest, France.
Cornec D; Université de Brest, INSERM, UMR1227, Centre Hospitalier Universitaire de Brest, Brest, France.
Rouvière B; Université de Brest, INSERM, UMR1227, Centre Hospitalier Universitaire de Brest, Brest, France.
Jamin C; Université de Brest, INSERM, UMR1227, Centre Hospitalier Universitaire de Brest, Brest, France.
Le Lann L; Université de Brest, INSERM, UMR1227, Centre Hospitalier Universitaire de Brest, Brest, France.
Borghi MO; University of Milan and Istituto Auxologico Italiano, IRCCS, Milan, Italy.
Aguilar-Quesada R; Biobanco del Sistema Sanitario Publico de Andalucía, Seville, Spain.
Renaudineau Y; Université de Brest, INSERM, UMR1227, Centre Hospitalier Universitaire de Brest, Brest, France.
Alarcón-Riquelme ME; Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research, Granada, Spain.
Pers JO; Université de Brest, INSERM, UMR1227, Centre Hospitalier Universitaire de Brest, Brest, France.
Hillion S; Université de Brest, INSERM, UMR1227, Centre Hospitalier Universitaire de Brest, Brest, France.
Pokaż więcej
Corporate Authors :
PRECISESADS Clinical Consortium
PRECISESADS Flow Cytometry Study Group
Źródło :
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Aug; Vol. 73 (8), pp. 1550-1561. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*immunology
Autoimmune Diseases/*immunology
B-Lymphocyte Subsets/*immunology
Cytokines/*immunology
Th1 Cells/*immunology
Adult ; Arthritis, Rheumatoid/blood ; Arthritis, Rheumatoid/immunology ; Autoantibodies/blood ; Autoimmune Diseases/blood ; Biomarkers/blood ; Cell Differentiation/immunology ; Cell Proliferation ; Cellular Microenvironment/immunology ; Chemokine CXCL10/blood ; Chemokine CXCL10/immunology ; Coculture Techniques ; Cross-Sectional Studies ; Cytokines/blood ; Female ; Humans ; Interferon-gamma/blood ; Interferon-gamma/immunology ; Interleukin-2/blood ; Interleukin-2/immunology ; Interleukin-6/blood ; Interleukin-6/immunology ; Lupus Erythematosus, Systemic/blood ; Lupus Erythematosus, Systemic/immunology ; Male ; Middle Aged ; Prospective Studies ; Receptor Cross-Talk/immunology ; Scleroderma, Systemic/blood ; Scleroderma, Systemic/immunology ; Sjogren's Syndrome/blood ; Sjogren's Syndrome/immunology
Czasopismo naukowe
Tytuł :
Myositis-Specific Autoantibodies as Relevant Adjusting Variables in Myositis Research: Comment on the Article by Hou et al.
Autorzy :
Pinal-Fernandez I; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health Bethesda, MD Johns Hopkins University School of Medicine Baltimore, MD and Universitat Oberta de Catalunya, Barcelona, Spain.
Mammen AL; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health Bethesda, MD and Johns Hopkins University School of Medicine, Baltimore, MD.
Pokaż więcej
Źródło :
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Aug; Vol. 73 (8), pp. 1564-1566. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural; Comment
MeSH Terms :
Autoantibodies*
Myositis*
Humans
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies